SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-026160
Filing Date
2023-08-01
Accepted
2023-08-01 07:15:41
Documents
14
Period of Report
2023-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50120
2 ex99-1.htm EX-99.1 114863
3 ex99-1_001.jpg GRAPHIC 3119
  Complete submission text file 0001493152-23-026160.txt   356513

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xtnt-20230801.xsd EX-101.SCH 3027
5 XBRL LABEL FILE xtnt-20230801_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE xtnt-20230801_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3228
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 231129639
SIC: 2836 Biological Products, (No Diagnostic Substances)